[Adenosine-3',5'-monophosphate phosphodiesterase of the cerebral cortex and the effect of cardiovascular preparations].
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000187:drug effects / Q000201:enzymology*; D004077:Digoxin / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology*; D007799:Lanatosides / Q000494:pharmacology; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D010946:Plants, Medicinal; D051381:Rats; D013328:Strophanthins / Q000494:pharmacology; D013805:Theobromine / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology*
D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D007546:Isoquinolines; D007799:Lanatosides; D013328:Strophanthins; D014970:Xanthines; D002110:Caffeine; D004077:Digoxin; D013806:Theophylline; D010208:Papaverine; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D013805:Theobromine
Fosfodiésteraza adenozin-3',5'-monofosfata kory golovnogo mozga i deĭstvie serdechno-sosudistykh preparatov.